Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

231.52
-0.8300-0.36%
Post-market: 227.76-3.7600-1.62%19:30 EDT
Volume:1.00M
Turnover:233.31M
Market Cap:15.03B
PE:15.83
High:236.00
Open:231.60
Low:230.39
Close:232.35
52wk High:266.38
52wk Low:128.80
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.24
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.13
PE(LYR):-39.64

Loading ...

Jazz Pharmaceuticals - No New Safety Signals Identified for Zepzelca in Lagoon Trial

THOMSON REUTERS
·
Jun 12

Jazz Pharmaceuticals Provides Update on Zepzelca® (Lurbinectedin) Phase 3 Lagoon Trial in Second-Line Small Cell Lung Cancer

THOMSON REUTERS
·
Jun 12

Jazz Pharmaceuticals - Phase 3 Lagoon Trial of Zepzelca in Second-Line Sclc Does Not Meet Primary Endpoint

THOMSON REUTERS
·
Jun 12

BofA Securities Raises Price Target on Jazz Pharmaceuticals to $307 From $281, Maintains Buy Rating

MT Newswires Live
·
Jun 10

Jazz Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Jun 10

Jazz Pharmaceuticals price target raised to $307 from $281 at BofA

TIPRANKS
·
Jun 10

Jazz Pharmaceuticals : Bofa Global Research Raises Price Objective to $307.00 From $281.00

THOMSON REUTERS
·
Jun 10

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 09

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $256 From $230

THOMSON REUTERS
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Jazz Pharmaceuticals (JAZZ) and Humana (HUM)

TIPRANKS
·
Jun 09

Jazz Pharma director Bruce C. Cozadd disposes of 6,000 shares for USD 1.41 million

Reuters
·
Jun 04

Jazz Pharmaceuticals (JAZZ) Gets a Hold from Bernstein

TIPRANKS
·
Jun 02

Jazz Pharma EVP, Chief Legal Officer Neena Patil disposes of USD 282,870.24 in common shares

Reuters
·
Jun 02

Jazz Pharma EVP, Chief Commercial Officer Samantha Pearce sells 6,907 shares for $1.63 million

Reuters
·
Jun 02

Jazz Pharma director Anne O'Riordan will not seek re-election at 2026 annual meeting

Reuters
·
May 30

Jazz Pharma director Rick E. Winningham disposes of 2,741 shares for $661,744.37

Reuters
·
May 28

Jazz director Heather Ann McSharry disposes of Jazz Pharma shares worth $482,000

Reuters
·
May 28

Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM

TIPRANKS
·
May 28

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
May 28

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Barclays

TIPRANKS
·
May 27